Third Harmonic Bio Inc.

NASDAQ: THRD · Real-Time Price · USD
5.38
-0.00 (-0.09%)
At close: Jul 30, 2025, 3:59 PM

Third Harmonic Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 35K 38K n/a
Gross Profit
n/a -35K -38K n/a
Operating Income
58.87M -43.95M -37.71M -19M
Interest Income
n/a 13.13M 2.55K 5.00
Pretax Income
45.47M -30.82M -35.16M -29.61M
Net Income
45.47M -30.82M -37.71M -29.61M
Selling & General & Admin
22.37M 19.99M 13.3M 3.26M
Research & Development
36.5M 23.96M 24.41M 15.75M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
58.87M 43.92M 37.71M 19M
Interest Expense
n/a n/a 2.55M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-58.87M 43.95M 37.71M 19M
Income Tax Expense
n/a n/a 2.55M -19K
Shares Outstanding (Basic)
41.73M 39.65M 39.38M 38.69M
Shares Outstanding (Diluted)
41.73M 39.65M 39.38M 38.69M
EPS (Basic)
1.09 -0.78 -0.96 -0.77
EPS (Diluted)
1.09 -0.78 -0.96 -0.77
EBITDA
-45.42M -30.79M -35.12M -10.61M
EBIT
n/a -30.82M -35.16M -29.61M
Depreciation & Amortization
n/a 35K 38K 19M